Citations (92)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Yan Chen, Lin Zhang, Lei Liu, Shixiu Sun, Xuyang Zhao, Yueyuan Wang, Yujie Zhang, Jun Du & Luo Gu. (2018) Rasip1 is a RUNX1 target gene and promotes migration of NSCLC cells. Cancer Management and Research 10, pages 4537-4552.
Read now
Read now
Sara Mongiorgi, Carlo Finelli, Yong Ryoul Yang, Cristina Clissa, James A. McCubrey, Anna Maria Billi, Lucia Manzoli, Pann-Ghill Suh, Lucio Cocco & Matilde Y. Follo. (2016) Inositide-dependent signaling pathways as new therapeutic targets in myelodysplastic syndromes. Expert Opinion on Therapeutic Targets 20:6, pages 677-687.
Read now
Read now
Arne Kutzner & Klaus Heese. (2016) Glutamate E15 and E171 are Hotspots in p60TRP-Related Cancer. Cancer Investigation 34:2, pages 64-69.
Read now
Read now
Beatrice Rubin, Halenya Monticelli, Marco Redaelli, Carla Mucignat, Susi Barollo, Loris Bertazza, Caterina Mian, Corrado Betterle, Maurizio Iacobone, Ambrogio Fassina, Marco Boscaro, Raffaele Pezzani & Franco Mantero. (2015) Mitogen-Activated Protein Kinase Pathway: Genetic Analysis of 95 Adrenocortical Tumors. Cancer Investigation 33:10, pages 526-531.
Read now
Read now
Pietro Santulli, Louis Marcellin, Claudia Tosti, Sandrine Chouzenoux, Olivier Cerles, Bruno Borghese, Frédéric Batteux & Charles Chapron. (2015) MAP kinases and the inflammatory signaling cascade as targets for the treatment of endometriosis?. Expert Opinion on Therapeutic Targets 19:11, pages 1465-1483.
Read now
Read now
Articles from other publishers (87)
Duancheng Guo, Longyun Ye, Weiding Wu, Xianjun Yu & Kaizhou Jin. (2023) Novel strategy for oncogenic alteration-induced lipid metabolism reprogramming in pancreatic cancer. Acta Biochimica et Biophysica Sinica 55:6, pages 923-937.
Crossref
Crossref
Wuling Liu, Babu Gajendran, Klarke M. Sample, Chunlin Wang, Anling Hu, Beiling Chen, Yanmei Li, Eldad Zacksenhaus & Yaacov Ben-David. (2022) A critical ETV4/Twist1/Vimentin axis in Ha-RAS-induced aggressive breast cancer. Cancer Gene Therapy 29:11, pages 1590-1599.
Crossref
Crossref
Marcos Paulo S. Damasio, Camila Sales Nascimento, Lidia M. Andrade, Vivian L. de Oliveira & Carlos Eduardo Calzavara-Silva. (2022) The role of T-cells in head and neck squamous cell carcinoma: From immunity to immunotherapy. Frontiers in Oncology 12.
Crossref
Crossref
Wenjie Peng, Pei Wu, Minghao Yuan, Bo Yuan, Lian Zhu, Jiesong Zhou & Qian Li. (2022) Potential Molecular Mechanisms of Recurrent and Progressive Meningiomas: A Review of the Latest Literature. Frontiers in Oncology 12.
Crossref
Crossref
Jonathan Thomas & Guru Sonpavde. (2022) Molecularly Targeted Therapy towards Genetic Alterations in Advanced Bladder Cancer. Cancers 14:7, pages 1795.
Crossref
Crossref
Ayelet Shai, Evleen Galouk, Reem Miari, Hala Tareef, Marei Sammar, Mouhammad Zeidan, Anwar Rayan & Mizied Falah. (2022) Inhibiting mutant KRAS G12D gene expression using novel peptide nucleic acid‑based antisense: A potential new drug candidate for pancreatic cancer. Oncology Letters 23:4.
Crossref
Crossref
Pablo Carabias, María V. Espelt, María L. Bacigalupo, Paola Rojas, Luciana Sarrias, Ayelén Rubin, Nicolás A. Saffioti, María T. Elola, Juan P. Rossi, Carlota Wolfenstein-Todel, Gabriel A. Rabinovich & María F. Troncoso. (2022) Galectin-1 confers resistance to doxorubicin in hepatocellular carcinoma cells through modulation of P-glycoprotein expression. Cell Death & Disease 13:1.
Crossref
Crossref
Laurène Alicia Lecaudey, Pooja Singh, Christian Sturmbauer, Anna Duenser, Wolfgang Gessl & Ehsan Pashay Ahi. (2021) Transcriptomics unravels molecular players shaping dorsal lip hypertrophy in the vacuum cleaner cichlid, Gnathochromis permaxillaris. BMC Genomics 22:1.
Crossref
Crossref
Yuan Cheng, Tao Zhang & Qing Xu. (2021) Therapeutic advances in non‐small cell lung cancer: Focus on clinical development of targeted therapy and immunotherapy. MedComm 2:4, pages 692-729.
Crossref
Crossref
Sahar F. Bannoura, Md. Hafiz Uddin, Misako Nagasaka, Farzeen Fazili, Mohammed Najeeb Al-Hallak, Philip A. Philip, Bassel El-Rayes & Asfar S. Azmi. (2021) Targeting KRAS in pancreatic cancer: new drugs on the horizon. Cancer and Metastasis Reviews 40:3, pages 819-835.
Crossref
Crossref
Jenny J. Li, Alexander R. Kovach, Margaret DeMonia, Katherine K. Slemmons, Kristianne M. Oristian, Candy Chen & Corinne M. Linardic. (2021) Expression of oncogenic HRAS in human Rh28 and RMS-YM rhabdomyosarcoma cells leads to oncogene-induced senescence. Scientific Reports 11:1.
Crossref
Crossref
Cameron M Hough, David N Purschke, Chenxi Huang, Lyubov V Titova, Olga V Kovalchuk, Brad J Warkentin & Frank A Hegmann. (2021) Intense terahertz pulses inhibit Ras signaling and other cancer-associated signaling pathways in human skin tissue models. Journal of Physics: Photonics 3:3, pages 034004.
Crossref
Crossref
June Pui Yin Lee, Annamarie Jacob Thomas, Siew Kheong Lum, Noor Hasni Shamsudin, Ling-Wei Hii, Chun-Wai Mai, Shew-Fung Wong & Chee-Onn Leong. (2021) Gene expression profiling of giant fibroadenomas of the breast. Surgical Oncology 37, pages 101536.
Crossref
Crossref
Francesco Palma, Alessandra Affinito, Silvia Nuzzo, Giuseppina Roscigno, Iolanda Scognamiglio, Francesco Ingenito, Lola Martinez, Monica Franzese, Mario Zanfardino, Andrea Soricelli, Alfonso Fiorelli, Gerolama Condorelli & Cristina Quintavalle. (2020) miR-34c-3p targets CDK1 a synthetic lethality partner of KRAS in non-small cell lung cancer. Cancer Gene Therapy 28:5, pages 413-426.
Crossref
Crossref
Junpeng Xu, Qingge Jia, Yan Zhang, Yuan Yuan, Tianqi Xu, Kangjie Yu, Jia Chai, Kaijing Wang, Ligang Chen, Tian Xiao & Mingyang Li. (2021) Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer. Pathology - Research and Practice 219, pages 153374.
Crossref
Crossref
Kotaro Sakamoto, Teruaki Masutani & Takatsugu Hirokawa. (2020) Generation of KS-58 as the first K-Ras(G12D)-inhibitory peptide presenting anti-cancer activity in vivo. Scientific Reports 10:1.
Crossref
Crossref
Hye Won Lee, Jason K. Sa, Antonio Gualberto, Catherine Scholz, Hyun Hwan Sung, Byong Chang Jeong, Han Yong Choi, Ghee Young Kwon & Se Hoon Park. (2020)
A Phase II Trial of Tipifarnib for Patients with Previously Treated, Metastatic Urothelial Carcinoma Harboring
HRAS
Mutations
. Clinical Cancer Research 26:19, pages 5113-5119.
Crossref
Crossref
Léo Aubert, Neethi Nandagopal, Zachary Steinhart, Geneviève Lavoie, Sami Nourreddine, Jacob Berman, Marc K. Saba-El-Leil, David Papadopoli, Sichun Lin, Traver Hart, Graham Macleod, Ivan Topisirovic, Louis Gaboury, Christoph J. Fahrni, Daniel Schramek, Sylvain Meloche, Stephane Angers & Philippe P. Roux. (2020) Copper bioavailability is a KRAS-specific vulnerability in colorectal cancer. Nature Communications 11:1.
Crossref
Crossref
Andy Göbel, Martina Rauner, Lorenz C. Hofbauer & Tilman D. Rachner. (2020) Cholesterol and beyond - The role of the mevalonate pathway in cancer biology. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1873:2, pages 188351.
Crossref
Crossref
Antoine Méant, Beichen Gao, Geneviève Lavoie, Sami Nourreddine, Flora Jung, Léo Aubert, Joseph Tcherkezian, Anne-Claude Gingras & Philippe P. Roux. (2020) Proteomic Analysis Reveals a Role for RSK in p120-catenin Phosphorylation and Melanoma Cell-Cell Adhesion. Molecular & Cellular Proteomics 19:1, pages 50-64.
Crossref
Crossref
Abbas J. Avval, Ahmad Majd, Naghmeh Gholipour, Kambiz A. Noghabi, Anna Ohradanova-Repic & Ghasem Ahangari. (2019) An Inventive Report of Inducing Apoptosis in Non-Small Cell Lung Cancer (NSCLC) Cell Lines by Transfection of MiR-4301. Anti-Cancer Agents in Medicinal Chemistry 19:13, pages 1609-1617.
Crossref
Crossref
Karolien Vanhove, Geert-Jan Graulus, Liesbet Mesotten, Michiel Thomeer, Elien Derveaux, Jean-Paul Noben, Wanda Guedens & Peter Adriaensens. (2019) The Metabolic Landscape of Lung Cancer: New Insights in a Disturbed Glucose Metabolism. Frontiers in Oncology 9.
Crossref
Crossref
Fengqian Chen, Martin P. Alphonse, Yan Liu & Qi Liu. (2019) Targeting Mutant KRAS for Anticancer Therapy. Current Topics in Medicinal Chemistry 19:23, pages 2098-2113.
Crossref
Crossref
Garazi Serna, Fiorella Ruiz-Pace, Fabiola Cecchi, Roberta Fasani, Jose Jimenez, Sheeno Thyparambil, Stefania Landolfi, Elena Elez, Ana Vivancos, Todd Hembrough, Josep Tabernero, Rodrigo Dienstmann & Paolo Nuciforo. (2019) Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer. Scientific Reports 9:1.
Crossref
Crossref
Cameron M. Hough, David N. Purschke, Chenxi Huang, Lyubov V. Titova, Olga Kovalchuk, Brad J. Warkentin & Frank A. Hegmann. (2019) Genomic Mechanisms of THz-Induced Cancer Dysregulation in Human Skin. Genomic Mechanisms of THz-Induced Cancer Dysregulation in Human Skin.
Rong Zhu, Xiaochen Xie, Nana Wang, Liang Chen & Yongqing Hong. (2019)
The T helper type 17/regulatory T cell imbalance was associated with Ras‐
GTP
ase overexpression in patients with pulmonary hypertension associated with chronic obstructive pulmonary disease
. Immunology 157:4, pages 304-311.
Crossref
Crossref
Kiichiro Teruya, Yoshihiro Kusumoto, Hiroshi Eto, Noboru Nakamichi & Sanetaka Shirahata. (2019) Selective Suppression of Cell Growth and Programmed Cell Death-Ligand 1 Expression in HT1080 Fibrosarcoma Cells by Low Molecular Weight Fucoidan Extract. Marine Drugs 17:7, pages 421.
Crossref
Crossref
Emily K. Kleczko, Jeff W. Kwak, Erin L. Schenk & Raphael A. Nemenoff. (2019) Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer. Frontiers in Immunology 10.
Crossref
Crossref
Lihong Wang-Bishop, Zheng Chen, Ahmed Gomaa, Albert Craig Lockhart, Safia Salaria, Jialiang Wang, Keeli B. Lewis, Jeffrey Ecsedy, Kay Washington, Robert Daniel Beauchamp & Wael El-Rifai. (2019) Inhibition of AURKA Reduces Proliferation and Survival of Gastrointestinal Cancer Cells With Activated KRAS by Preventing Activation of RPS6KB1. Gastroenterology 156:3, pages 662-675.e7.
Crossref
Crossref
Wagner Ricardo Montor, Andrei Ronaldo Oliveira Silva Escar Salas & Fabiana Henriques Machado de Melo. (2018) Receptor tyrosine kinases and downstream pathways as druggable targets for cancer treatment: the current arsenal of inhibitors. Molecular Cancer 17:1.
Crossref
Crossref
Marta Román, Iosune Baraibar, Inés López, Ernest Nadal, Christian Rolfo, Silvestre Vicent & Ignacio Gil-Bazo. (2018) KRAS oncogene in non-small cell lung cancer: clinical perspectives on the treatment of an old target. Molecular Cancer 17:1.
Crossref
Crossref
Catherine G Fischer & Laura D Wood. (2018) From somatic mutation to early detection: insights from molecular characterization of pancreatic cancer precursor lesions. The Journal of Pathology 246:4, pages 395-404.
Crossref
Crossref
Enrica Saponara, Michele Visentin, Francesco Baschieri, Gitta Seleznik, Paola Martinelli, Irene Esposito, Johanna Buschmann, Rong Chen, Rossella Parrotta, Nathalie Borgeaud, Marta Bombardo, Ermanno Malagola, Amedeo Caflisch, Hesso Farhan, Rolf Graf & Sabrina Sonda. (2018) Serotonin uptake is required for Rac1 activation in Kras‐induced acinar‐to‐ductal metaplasia in the pancreas. The Journal of Pathology 246:3, pages 352-365.
Crossref
Crossref
Kara M. Ruicci, Nicole Pinto, Mohammed I. Khan, John Yoo, Kevin Fung, Danielle MacNeil, Joe S. Mymryk, John W. Barrett & Anthony C. Nichols. (2018) ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition. Oral Oncology 84, pages 95-103.
Crossref
Crossref
Cameron M. Hough, David N. Purschke, Chenxi Huang, Lyubov V. Titova, Olga Kovalchuk, Brad J. Warkentin & Frank A. Hegmann. (2018) Topology-Based Prediction of Pathway Dysregulation Induced by Intense Terahertz Pulses in Human Skin Tissue Models. Journal of Infrared, Millimeter, and Terahertz Waves 39:9, pages 887-898.
Crossref
Crossref
Agata Adelajda Krygowska & Esther Castellano. (2018) PI3K: A Crucial Piece in the RAS Signaling Puzzle. Cold Spring Harbor Perspectives in Medicine 8:6, pages a031450.
Crossref
Crossref
Wookjin Shin, Sang-Kyu Lee, Jeong-Ha Hwang, Jong-Chan Park, Yong-Hee Cho, Eun Ji Ro, Yeonhwa Song, Haeng Ran Seo & Kang-Yell Choi. (2018) Identification of Ras-degrading small molecules that inhibit the transformation of colorectal cancer cells independent of β-catenin signaling. Experimental & Molecular Medicine 50:6, pages 1-10.
Crossref
Crossref
Xin Yao Qiu, Dian Xing Hu, Wen-Qiang Chen, Ruo Qiao Chen, Shi Rui Qian, Chun Yang Li, Yuan Jun Li, Xin Xin Xiong, Di Liu, Feng Pan, Shang Bin Yu & Xiao Qian Chen. (2018) PD-L1 confers glioblastoma multiforme malignancy via Ras binding and Ras/Erk/EMT activation. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1864:5, pages 1754-1769.
Crossref
Crossref
Vincent Bernard & Anirban Maitra. 2018. The Pancreas. The Pancreas
865
871
.
Thibault Houles & Philippe P. Roux. (2018) Defining the role of the RSK isoforms in cancer. Seminars in Cancer Biology 48, pages 53-61.
Crossref
Crossref
Yi Yu, Terence Hall, Sudharshan Eathiraj, Michael J. Wick, Brian Schwartz & Giovanni Abbadessa. (2017) In-vitro and in-vivo combined effect of ARQ 092, an AKT inhibitor, with ARQ 087, a FGFR inhibitor. Anti-Cancer Drugs 28:5, pages 503-513.
Crossref
Crossref
Ayumu Niida, Shigekazu Sasaki, Kazuko Yonemori, Tomoya Sameshima, Masahiro Yaguchi, Taiji Asami, Kotaro Sakamoto & Masahiro Kamaura. (2017) Investigation of the structural requirements of K-Ras(G12D) selective inhibitory peptide KRpep-2d using alanine scans and cysteine bridging. Bioorganic & Medicinal Chemistry Letters 27:12, pages 2757-2761.
Crossref
Crossref
Yuanyuan Ji, Zhidong Wang, Zongfang Li, Na Huang, Haiyan Chen, Baohua Li & Bo Hui. (2017) Silencing IGF-II impairs C-myc and N-ras expressions of SMMC-7721 cells via suppressing FAK/PI3K/Akt signaling pathway. Cytokine 90, pages 44-53.
Crossref
Crossref
Adam B. Keeton, E. Alan Salter & Gary A. Piazza. (2017) The RAS–Effector Interaction as a Drug Target. Cancer Research 77:2, pages 221-226.
Crossref
Crossref
A.B. Keeton & G.A. Piazza. 2017. Conquering RAS. Conquering RAS
135
154
.
Lhassane Ismaili, Alejandro Romero, María do Carmo Carreiras & José Marco-Contelles. 2017. Design of Hybrid Molecules for Drug Development. Design of Hybrid Molecules for Drug Development
5
46
.
Chunling Jiang, Tao Song, Jingao Li, Fan Ao, Xiaochang Gong, Yicheng Lu, Chenran Zhang, Liangyu Chen, Yunhui Liu, Hua He & Ouping Huang. (2016) RAS Promotes Proliferation and Resistances to Apoptosis in Meningioma. Molecular Neurobiology 54:1, pages 779-787.
Crossref
Crossref
Karen M. Mann, Haoqiang Ying, Joseph Juan, Nancy A. Jenkins & Neal G. Copeland. (2016) KRAS-related proteins in pancreatic cancer. Pharmacology & Therapeutics 168, pages 29-42.
Crossref
Crossref
Lars Björn Riecken, Ansgar Zoch, Ulrike Wiehl, Sabine Reichert, Ingmar Scholl, Yan Cui, Mirjana Ziemer, Ulf Anderegg, Christian Hagel & Helen Morrison. (2016) CPI-17 drives oncogenic Ras signaling in human melanomas via Ezrin-Radixin-Moesin family proteins. Oncotarget 7:48, pages 78242-78254.
Crossref
Crossref
. 2016. Super-Resolution Imaging in Biomedicine. Super-Resolution Imaging in Biomedicine
321
350
.
Julian C. Bahr, Robert W. Robey, Victoria Luchenko, Agnes Basseville, Arup R. Chakraborty, Hanna Kozlowski, Gary T. Pauly, Paresma Patel, Joel P. Schneider, Michael M. Gottesman & Susan E. Bates. (2016) Blocking downstream signaling pathways in the context of HDAC inhibition promotes apoptosis preferentially in cells harboring mutant Ras. Oncotarget 7:43, pages 69804-69815.
Crossref
Crossref
Atiye Seda Yar Saglam, Ebru Alp, Zubeyir Elmazoglu & Emine Sevda Menevse. (2016) Effect of API-1 and FR180204 on cell proliferation and apoptosis in human DLD-1 and LoVo colorectal cancer cells. Oncology Letters 12:4, pages 2463-2474.
Crossref
Crossref
Xuanzhu Zhou, Wei Zheng, G.A. Nagana Gowda, Daniel Raftery, Shawn S. Donkin, Brian Bequette & Dorothy Teegarden. (2016) 1,25-Dihydroxyvitamin D inhibits glutamine metabolism in Harvey-ras transformed MCF10A human breast epithelial cell. The Journal of Steroid Biochemistry and Molecular Biology 163, pages 147-156.
Crossref
Crossref
Chao-Feng Lin, Han-Li Huang, Chieh-Yu Peng, Yu-Ching Lee, Hui-Po Wang, Che-Ming Teng & Shiow-Lin Pan. (2016) TW-01, a piperazinedione-derived compound, inhibits Ras-mediated cell proliferation and angioplasty-induced vascular restenosis. Toxicology and Applied Pharmacology 305, pages 194-202.
Crossref
Crossref
Olga N. Ilinskaya, Indrabahadur Singh, Elena Dudkina, Vera Ulyanova, Airat Kayumov & Guillermo Barreto. (2016) Direct inhibition of oncogenic KRAS by Bacillus pumilus ribonuclease (binase). Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 1863:7, pages 1559-1567.
Crossref
Crossref
Elizabeth R. Plimack & Daniel M. Geynisman. (2016) Targeted Therapy for Metastatic Urothelial Cancer: A Work in Progress. Journal of Clinical Oncology 34:18, pages 2088-2092.
Crossref
Crossref
DEBAO QU, HUI HUANG, JIEHUI DI, KEYU GAO, ZHENG LU & JUNNIAN ZHENG. (2016) Structure, functional regulation and signaling properties of Rap2B. Oncology Letters 11:4, pages 2339-2346.
Crossref
Crossref
Feng Wang & Stephen W. Fesik. 2016. Fragment‐based Drug Discovery Lessons and Outlook. Fragment‐based Drug Discovery Lessons and Outlook
371
390
.
Bingliang Fang. (2016) RAS signaling and anti-RAS therapy: lessons learned from genetically engineered mouse models, human cancer cells, and patient-related studies. Acta Biochimica et Biophysica Sinica 48:1, pages 27-38.
Crossref
Crossref
Roseli García-Cruz, Maria Camats, George A. Calin, Chang-Gong Liu, Stefano Volinia, Cristian Taccioli, Carlo M. Croce & Montse Bach-Elias. (2015) The role of p19 and p21 H-Ras proteins and mutants in miRNA expression in cancer and a Costello syndrome cell model. BMC Medical Genetics 16:1.
Crossref
Crossref
MARIACRISTINA DI MARCO, ANNALISA ASTOLFI, ELISA GRASSI, SILVIA VECCHIARELLI, MARINA MACCHINI, VALENTINA INDIO, RICCARDO CASADEI, CLAUDIO RICCI, MARIELDA D'AMBRA, GIOVANNI TAFFURELLI, CARLA SERRA, GIORGIO ERCOLANI, DONATELLA SANTINI, ANTONIA D'ERRICO, ANTONIO DANIELE PINNA, FRANCESCO MINNI, SANDRA DURANTE, LAURA RAFFAELLA MARTELLA & GUIDO BIASCO. (2015) Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array. Molecular Medicine Reports 12:5, pages 7479-7484.
Crossref
Crossref
Haizhen Wang, Tao Yang & Xiangwei Wu. (2015) 5-Fluorouracil preferentially sensitizes mutant KRAS non-small cell lung carcinoma cells to TRAIL-induced apoptosis. Molecular Oncology 9:9, pages 1815-1824.
Crossref
Crossref
Saluja Kaduwal, Woo-Jeong Jeong, Jong-Chan Park, Kug Hwa Lee, Young-Mi Lee, Soung-Hoo Jeon, Yong-Beom Lim, Do Sik Min & Kang-Yell Choi. (2015) Sur8/Shoc2 promotes cell motility and metastasis through activation of Ras-PI3K signaling. Oncotarget 6:32, pages 33091-33105.
Crossref
Crossref
Denise Zwanziger, Julia Badziong, Saskia Ting, Lars Christian Moeller, Kurt Werner Schmid, Udo Siebolts, Claudia Wickenhauser, Henning Dralle & Dagmar Fuehrer. (2015) The impact of CLAUDIN-1 on follicular thyroid carcinoma aggressiveness. Endocrine-Related Cancer 22:5, pages 819-830.
Crossref
Crossref
Dominic Leiser, Michaela Medová, Kei Mikami, Lluís Nisa, Deborah Stroka, Andree Blaukat, Friedhelm Bladt, Daniel M. Aebersold & Yitzhak Zimmer. (2015) KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells. Molecular Oncology 9:7, pages 1434-1446.
Crossref
Crossref
Elena Puerta-García, Marisa Cañadas-Garre & Miguel Ángel Calleja-Hernández. (2015) Molecular biomarkers in colorectal carcinoma. Pharmacogenomics 16:10, pages 1189-1222.
Crossref
Crossref
Wilhelm Engström, Philippa Darbre, Staffan Eriksson, Linda Gulliver, Tove Hultman, Michalis V. Karamouzis, James E. Klaunig, Rekha Mehta, Kim Moorwood, Thomas Sanderson, Hideko Sone, Pankaj Vadgama, Gerard Wagemaker, Andrew Ward, Neetu Singh, Fahd Al-Mulla, Rabeah Al-Temaimi, Amedeo Amedei, Anna Maria Colacci, Monica Vaccari, Chiara Mondello, A.Ivana Scovassi, Jayadev Raju, Roslida A. Hamid, Lorenzo Memeo, Stefano Forte, Rabindra Roy, Jordan Woodrick, Hosni K. Salem, Elizabeth Ryan, Dustin G. Brown & William H. Bisson. (2015) The potential for chemical mixtures from the environment to enable the cancer hallmark of sustained proliferative signalling. Carcinogenesis 36:Suppl 1, pages S38-S60.
Crossref
Crossref
Lin Wang, Li Lin, Xi Chen, Li Sun, Yulin Liao, Na Huang & Wangjun Liao. (2015) Metastasis-associated in colon cancer-1 promotes vasculogenic mimicry in gastric cancer by upregulating TWIST1/2. Oncotarget 6:13, pages 11492-11506.
Crossref
Crossref
Rui Hu, Chengbin Yang, Yucheng Wang, Guimiao Lin, Wei Qin, Qingling Ouyan, Wing-Cheung Law, Quoc Toan Nguyen, Ho Sup Yoon, Xiaomei Wang, Ken-Tye Yong & Ben Zhong Tang. (2014) Aggregation-induced emission (AIE) dye loaded polymer nanoparticles for gene silencing in pancreatic cancer and their in vitro and in vivo biocompatibility evaluation. Nano Research 8:5, pages 1563-1576.
Crossref
Crossref
Jillian A. Parker & Carla Mattos. (2015) The Ras–Membrane Interface: Isoform-Specific Differences in the Catalytic Domain. Molecular Cancer Research 13:4, pages 595-603.
Crossref
Crossref
Jianbiao Zhou, Ying Qing Ching & Wee-Joo Chng. (2015) Aberrant nuclear factor-kappa B activity in acute myeloid Leukemia: from molecular pathogenesis to therapeutic target. Oncotarget 6:8, pages 5490-5500.
Crossref
Crossref
Andrea Teague, Kian-Huat Lim & Andrea Wang-Gillam. (2015) Advanced pancreatic adenocarcinoma: a review of current treatment strategies and developing therapies. Therapeutic Advances in Medical Oncology 7:2, pages 68-84.
Crossref
Crossref
Sunny Guin & Dan Theodorescu. (2015) The RAS-RAL axis in cancer: evidence for mutation-specific selectivity in non-small cell lung cancer. Acta Pharmacologica Sinica 36:3, pages 291-297.
Crossref
Crossref
Yong Ling, Zhiqiang Wang, Xuemin Wang, Xianghua Li, Xinyang Wang, Wei Zhang, Hong Dai, Li Chen & Yihua Zhang. (2015) Hybrid Molecule from Farnesylthiosalicylic Acid-diamine and Phenylpropenoic Acid as Ras-related Signaling Inhibitor with Potent Antitumor Activities. Chemical Biology & Drug Design 85:2, pages 145-152.
Crossref
Crossref
Lars Björn Riecken, Hasan Tawamie, Carsten Dornblut, Rebecca Buchert, Amina Ismayel, Alexander Schulz, Johannes Schumacher, Heinrich Sticht, Katja J. Pohl, Yan Cui, André Reis, Helen Morrison & Rami Abou Jamra. (2015) Inhibition of RAS Activation Due to a Homozygous Ezrin Variant in Patients with Profound Intellectual Disability. Human Mutation 36:2, pages 270-278.
Crossref
Crossref
Chengbin Yang, Rui Hu, Tommy Anderson, Yucheng Wang, Guimiao Lin, Wing-Cheung Law, Wei-Jen Lin, Quoc Toan Nguyen, Hui Ting Toh, Ho Sup Yoon, Chih-Kuang Chen & Ken-Tye Yong. (2015) Biodegradable nanoparticle-mediated K-ras down regulation for pancreatic cancer gene therapy. Journal of Materials Chemistry B 3:10, pages 2163-2172.
Crossref
Crossref
Damian Borys, Roman Jaksik, Michał Krześlak, Jarosław Śmieja & Andrzej Świerniak. 2015. Propagation Phenomena in Real World Networks. Propagation Phenomena in Real World Networks
225
256
.
Michael A. Davies. 2015. BRAF Targets in Melanoma. BRAF Targets in Melanoma
105
135
.
Zhi-Qiang Wang, Ren-An Chang, Hai-Ying Huang, Xue-Min Wang, Xin-Yang Wang, Li Chen & Yong Ling. (2014) Synthesis and biological evaluation of novel farnesylthiosalicylic acid/salicylic acid hybrids as potential anti-tumor agents. Chinese Chemical Letters 25:12, pages 1545-1549.
Crossref
Crossref
Lisa A. Radkay, Simion I. Chiosea, Raja R. Seethala, Steven P. Hodak, Shane O. LeBeau, Linwah Yip, Kelly L. McCoy, Sally E. Carty, Karen E. Schoedel, Marina N. Nikiforova, Yuri E. Nikiforov & N. Paul Ohori. (2014)
Thyroid nodules with
KRAS
mutations are different from nodules with
NRAS
and
HRAS
mutations with regard to cytopathologic and histopathologic outcome characteristics
. Cancer Cytopathology 122:12, pages 873-882.
Crossref
Crossref
Zhumei Shi, Qiudan Chen, Chongyong Li, Lin Wang, Xu Qian, Chengfei Jiang, Xue Liu, Xiefeng Wang, Hai Li, Chunsheng Kang, Tao Jiang, Ling-Zhi Liu, Yongping You, Ning Liu & Bing-Hua Jiang. (2014) MiR-124 governs glioma growth and angiogenesis and enhances chemosensitivity by targeting R-Ras and N-Ras. Neuro-Oncology 16:10, pages 1341-1353.
Crossref
Crossref
E. Yu. Kochetkova, T. V. Bykova, S. G. Zubova & T. V. Pospelova. (2014) The role of the MEK/ERK pathway in regulation of HDACI-induced senescence of transformed rat embryo fibroblasts. Cell and Tissue Biology 8:5, pages 374-383.
Crossref
Crossref
Jaclyn E. Quin, Jennifer R. Devlin, Donald Cameron, Kate M. Hannan, Richard B. Pearson & Ross D. Hannan. (2014) Targeting the nucleolus for cancer intervention. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1842:6, pages 802-816.
Crossref
Crossref
Asami Takashima, Brandon English, Zhihong Chen, Juxiang Cao, Rutao Cui, Robert M. Williams & Douglas V. Faller. (2014) Protein Kinase Cδ Is a Therapeutic Target in Malignant Melanoma with NRAS Mutation. ACS Chemical Biology 9:4, pages 1003-1014.
Crossref
Crossref
Matthew J Smith & Mitsuhiko Ikura. (2014) Integrated RAS signaling defined by parallel NMR detection of effectors and regulators. Nature Chemical Biology 10:3, pages 223-230.
Crossref
Crossref
Camila Tainah da Silva & Miriam Galvonas Jasiulionis. (2014) Relação entre estresse oxidativo, alterações epigenéticas e câncer. Ciência e Cultura 66:1, pages 38-42.
Crossref
Crossref
Min Luo, Fan Yang, Sheng-xin Huang, Zhi-peng Kuang, Xiao-ling Luo, Yuan-dong Li, Ji-ning Wu & Yu-an Xie. (2012) Two-Stage Model of Chemically Induced Hepatocellular Carcinoma in Mouse. Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics 20:11, pages 517-528.
Crossref
Crossref